Human immunodeficiency virus genotype and hypertriglyceridemia. (Q44060430)

PubMed publication ID

12112393

29 November 2017

title

Human immunodeficiency virus genotype and hypertriglyceridemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

Soni J Anderson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

John F Bradley

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

Andrea Ferreira-Gonzalez

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

Carleton T Garrett

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

publication date

1 January 2002

1 reference

PubMed publication ID

12112393

Journal of Clinical Laboratory Analysis

29 November 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

page(s)

202-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Sex differences in HAART-associated dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Mitochondrial toxicity and HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Influence of protease inhibitor therapy on lipoprotein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Virological and immunological characteristics of HIV treatment failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.10042

Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy

21 January 2018

1 reference

12 December 2020

Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex

1 reference

12 December 2020

Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99

1 reference

12 December 2020

Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.

1 reference

12 December 2020

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

1 reference

12 December 2020

Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1002/JCLA.10042

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json

12 May 2020

PubMed publication ID

12112393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6808024&resulttype=core&format=json